Immuno-oncology approaches in uveal melanoma: tebentafusp and beyond
Uveal melanoma (UM) is the most common ocular malignancy in adults, associated with the poorest prognosis, with metastatic disease occurring in up to 50% of patients. In contrast to metastatic cutaneous melanoma, the use of immune checkpoint inhibitors is associated with poor outcomes in metastatic...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2023-09-01
|
| Серии: | Immuno-Oncology and Technology |
| Предметы: | |
| Online-ссылка: | http://www.sciencedirect.com/science/article/pii/S259001882300014X |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|